Drug Search Results
More Filters [+]

Altretamine

Alternative Names: altretamine, hexalen
Latest Update: 2013-02-04
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: DNA Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | Colombia | Cyprus | France | Germany | India | Italy | New Zealand | Pakistan | Peru | Portugal | Russia | Sweden | Thailand | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Altretamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title